Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.06 by 33.33 percent. This is a 166.67 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $89.582 million which beat the analyst consensus estimate of $87.757 million by 2.08 percent. This is a 25.76 percent increase over sales of $71.234 million the same period last year.
Cellebrite DI Q1 2024 Adj EPS $0.08 Beats $0.06 Estimate, Sales $89.582M Beat $87.757M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.